Amount Raised
$35 Million
Investors
Cpt CapitalBunge VenturesSynthesis Capital
Description
Equinom, the company on a mission to cultivate better food from the ground up, has announced a $35 million tranche of funding to bring more of its optimized plant protein ingredients to market. The capital raise was led by Synthesis Capital (Synthesis), a leading global food technology and alternative protein investor, with additional investment from Praesidium, Bunge Ventures, the for-profit global investment arm of Bunge, BayWa, CPT Capital and returning investors Fortissimo and Phoenix. This brings the total funding for Equinom to over $71 million to date.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech